ARTICLE | Distillery Therapeutics
Therapeutics: Annexin A1 (ANXA1)
March 5, 2015 8:00 AM UTC
Mouse studies suggest plaque-targeting nanoparticles loaded with an ANXA1 peptide could help prevent cardiac events in atherosclerosis patients. Nanoparticles targeting the collagen type IV component ...